verified SJR 1,408 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

United States · Neoplasia Press, Inc.

workspace_premium Q1 — Oncology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Translational Oncology

Translational Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 78. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2070 €. The scope of the journal is focused on translational oncology, cancer, genetics, endocrinology, tumour. It has an SJR impact factor of 1,408 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,408.

Publisher: Neoplasia Press, Inc.

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,408 Q1

H-index 78

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

18 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

2.070 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,408

H-index

78

Docs (year)

352

Docs 3y

883

Total refs

19257

Cites 3y

4280

Citable 3y

864

Cites/Doc 2y

4.18

Ref/Doc

54.71

Immediate OA

2070 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review